Altimmune
ALT
$7.30
Share price
1.53%
Change (1 day)
46.59%
Change (1 year)
Categories
Altimmune (ALT) - P/B ratio
P/B ratio as of May 2024 : 2.63
According to Altimmune's latest financial reports the company has a price-to-book ratio of 2.63.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Altimmune - P/B ratio (from 2005 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.11 | -28.64% |
| 2022-12-31 | 4.36 | 138.75% |
| 2021-12-31 | 1.83 | -1.45% |
| 2020-12-31 | 1.85 | 191.76% |
| 2019-12-31 | 0.6358 | 64.24% |
| 2018-12-31 | 0.3871 | -39.51% |
| 2017-12-31 | 0.6399 | -90.5% |
| 2016-12-31 | 6.73 | -8.35% |
| 2015-12-31 | 7.35 | 16.63% |
| 2014-12-31 | 6.30 | -52.5% |
| 2013-12-31 | 13.3 | 185.88% |
| 2012-12-31 | 4.64 | 19.93% |
| 2011-12-31 | 3.87 | -75.85% |
| 2010-12-31 | 16.0 | -8.41% |
| 2009-12-31 | 17.5 | 457.02% |
| 2008-12-31 | 3.14 | 46.01% |
| 2007-12-31 | 2.15 | -104.61% |
| 2006-12-31 | -46.7 | -3255.64% |
| 2005-12-31 | 1.48 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -75.16% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -25.41% | 🇺🇸 USA |